The Role of Biomechanics in the Characterization and Monitoring of Cardiac Infectious Diseases (BIOCARD)

The Role of Biomechanics in the Characterization and Monitoring of Cardiac Infectious Diseases (BIOCARD) - BIOCARD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039379

Enrollment

Registered

2026-04-23

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac infectious disease

Interventions

Group 1: Magnetic Resonance Elastography (MRE) 1. Establishment and adaptation of the technique

development of SOPs • Setup and adaptation of MRE hardware and software components for cardiac applications. • Development of an algorithm for quantifying cardiac biomechanics using mechanical (gravit

GT) MRE, in collaboration with the Laboratory of Vascular Translational Science in Paris (Université Paris). • Comparison of MRE performance at 1.5T and 3T MRI systems to assess the influence of field

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Clinical suspicion of (peri-)myocarditis based on symptoms, ECG findings, and laboratory results. • Diagnostic confirmation of (peri-)myocarditis. • Biopsy-proven (peri-)myocarditis.

Exclusion criteria

Exclusion criteria: • Contraindications to MRI (e.g., claustrophobia, metallic implants, morbid obesity). • Pregnancy. • Lack of written informed consent (e.g., refusal to participate or inability to provide informed consent).

Design outcomes

Primary

Measure	Time frame
Mortality (follow-up time of max. 12 months).	—

Secondary

Measure	Time frame
Hospitalization	—

Countries

Germany

Contacts

Public ContactVitali Koch

Universitätsklinik Frankfurt

v.koch@med.uni-frankfurt.de+4915251749220

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026